The molecular genetics of pancreatic ductal carcinoma

T. A. Sohn

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Pancreatic ductal carcinoma remains the 4th leading cause of cancer death in both men and women in the United States, with an overall 5-year survival of less than 3%. Over the last decade, significant advances have been made in our understanding of the molecular biology of pancreatic ductal carcinoma, with pancreatic cancer now considered one of the better characterized neoplasms at the genetic level. The advances in the understanding of the molecular genetics of pancreatic cancer initially focused on events that occur in the development and early genetic progression of the disease. This progression has been associated with the accumulation of multiple genetic alterations in various cancer-causing genes, leading to the development of a histological and genetic progression model. In the model, pancreatic cancer develops from non-invasive intraepithelial precursor lesions termed pancreatic intraepithelial neoplasias, with each progressive stage associated with accumulated mutations in oncogenes, tumor-suppressor genes, and mismatch repair genes. Other aspects of the development of pancreatic ductal carcinoma, such as tumor invasion, tumor-stromal interaction, metastasis, and chemotherapeutic resistance are more poorly understood. Recent studies utilizing global gene expression methodologies have provided insight into some of these processes and have allowed for the development of potential tumor markers which could be used for early detection and diagnosis of this difficult disease. In order to improve the survival of patients with pancreatic carcinoma, we need to better understand the fundamental changes that occur in pancreatic ductal carcinoma. The following article reviews the genetic mutations and syndromes known to be associated with pancreatic ductal carcinoma as well as recent advances in the study of global gene expression.

Original languageEnglish (US)
Pages (from-to)561-574
Number of pages14
JournalMinerva Chirurgica
Volume57
Issue number5
StatePublished - 2002
Externally publishedYes

Fingerprint

Pancreatic Ductal Carcinoma
Molecular Biology
Pancreatic Neoplasms
Neoplasms
Gene Expression
Mutation
Inborn Genetic Diseases
DNA Mismatch Repair
Survival
Neoplasm Genes
Genetic Models
Tumor Biomarkers
Tumor Suppressor Genes
Oncogenes
Early Diagnosis
Cause of Death
Neoplasm Metastasis
Genes

Keywords

  • Oncogenes
  • Pancreatic ducts
  • Pancreatic neoplasms, diagnosis
  • Pancreatic neoplasms, genetics

ASJC Scopus subject areas

  • Surgery

Cite this

The molecular genetics of pancreatic ductal carcinoma. / Sohn, T. A.

In: Minerva Chirurgica, Vol. 57, No. 5, 2002, p. 561-574.

Research output: Contribution to journalArticle

Sohn, TA 2002, 'The molecular genetics of pancreatic ductal carcinoma', Minerva Chirurgica, vol. 57, no. 5, pp. 561-574.
Sohn, T. A. / The molecular genetics of pancreatic ductal carcinoma. In: Minerva Chirurgica. 2002 ; Vol. 57, No. 5. pp. 561-574.
@article{cc65f66c58c748858292a702d5bdfcdb,
title = "The molecular genetics of pancreatic ductal carcinoma",
abstract = "Pancreatic ductal carcinoma remains the 4th leading cause of cancer death in both men and women in the United States, with an overall 5-year survival of less than 3{\%}. Over the last decade, significant advances have been made in our understanding of the molecular biology of pancreatic ductal carcinoma, with pancreatic cancer now considered one of the better characterized neoplasms at the genetic level. The advances in the understanding of the molecular genetics of pancreatic cancer initially focused on events that occur in the development and early genetic progression of the disease. This progression has been associated with the accumulation of multiple genetic alterations in various cancer-causing genes, leading to the development of a histological and genetic progression model. In the model, pancreatic cancer develops from non-invasive intraepithelial precursor lesions termed pancreatic intraepithelial neoplasias, with each progressive stage associated with accumulated mutations in oncogenes, tumor-suppressor genes, and mismatch repair genes. Other aspects of the development of pancreatic ductal carcinoma, such as tumor invasion, tumor-stromal interaction, metastasis, and chemotherapeutic resistance are more poorly understood. Recent studies utilizing global gene expression methodologies have provided insight into some of these processes and have allowed for the development of potential tumor markers which could be used for early detection and diagnosis of this difficult disease. In order to improve the survival of patients with pancreatic carcinoma, we need to better understand the fundamental changes that occur in pancreatic ductal carcinoma. The following article reviews the genetic mutations and syndromes known to be associated with pancreatic ductal carcinoma as well as recent advances in the study of global gene expression.",
keywords = "Oncogenes, Pancreatic ducts, Pancreatic neoplasms, diagnosis, Pancreatic neoplasms, genetics",
author = "Sohn, {T. A.}",
year = "2002",
language = "English (US)",
volume = "57",
pages = "561--574",
journal = "Minerva Chirurgica",
issn = "0026-4733",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "5",

}

TY - JOUR

T1 - The molecular genetics of pancreatic ductal carcinoma

AU - Sohn, T. A.

PY - 2002

Y1 - 2002

N2 - Pancreatic ductal carcinoma remains the 4th leading cause of cancer death in both men and women in the United States, with an overall 5-year survival of less than 3%. Over the last decade, significant advances have been made in our understanding of the molecular biology of pancreatic ductal carcinoma, with pancreatic cancer now considered one of the better characterized neoplasms at the genetic level. The advances in the understanding of the molecular genetics of pancreatic cancer initially focused on events that occur in the development and early genetic progression of the disease. This progression has been associated with the accumulation of multiple genetic alterations in various cancer-causing genes, leading to the development of a histological and genetic progression model. In the model, pancreatic cancer develops from non-invasive intraepithelial precursor lesions termed pancreatic intraepithelial neoplasias, with each progressive stage associated with accumulated mutations in oncogenes, tumor-suppressor genes, and mismatch repair genes. Other aspects of the development of pancreatic ductal carcinoma, such as tumor invasion, tumor-stromal interaction, metastasis, and chemotherapeutic resistance are more poorly understood. Recent studies utilizing global gene expression methodologies have provided insight into some of these processes and have allowed for the development of potential tumor markers which could be used for early detection and diagnosis of this difficult disease. In order to improve the survival of patients with pancreatic carcinoma, we need to better understand the fundamental changes that occur in pancreatic ductal carcinoma. The following article reviews the genetic mutations and syndromes known to be associated with pancreatic ductal carcinoma as well as recent advances in the study of global gene expression.

AB - Pancreatic ductal carcinoma remains the 4th leading cause of cancer death in both men and women in the United States, with an overall 5-year survival of less than 3%. Over the last decade, significant advances have been made in our understanding of the molecular biology of pancreatic ductal carcinoma, with pancreatic cancer now considered one of the better characterized neoplasms at the genetic level. The advances in the understanding of the molecular genetics of pancreatic cancer initially focused on events that occur in the development and early genetic progression of the disease. This progression has been associated with the accumulation of multiple genetic alterations in various cancer-causing genes, leading to the development of a histological and genetic progression model. In the model, pancreatic cancer develops from non-invasive intraepithelial precursor lesions termed pancreatic intraepithelial neoplasias, with each progressive stage associated with accumulated mutations in oncogenes, tumor-suppressor genes, and mismatch repair genes. Other aspects of the development of pancreatic ductal carcinoma, such as tumor invasion, tumor-stromal interaction, metastasis, and chemotherapeutic resistance are more poorly understood. Recent studies utilizing global gene expression methodologies have provided insight into some of these processes and have allowed for the development of potential tumor markers which could be used for early detection and diagnosis of this difficult disease. In order to improve the survival of patients with pancreatic carcinoma, we need to better understand the fundamental changes that occur in pancreatic ductal carcinoma. The following article reviews the genetic mutations and syndromes known to be associated with pancreatic ductal carcinoma as well as recent advances in the study of global gene expression.

KW - Oncogenes

KW - Pancreatic ducts

KW - Pancreatic neoplasms, diagnosis

KW - Pancreatic neoplasms, genetics

UR - http://www.scopus.com/inward/record.url?scp=0036399762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036399762&partnerID=8YFLogxK

M3 - Article

VL - 57

SP - 561

EP - 574

JO - Minerva Chirurgica

JF - Minerva Chirurgica

SN - 0026-4733

IS - 5

ER -